Rezultati - van Alphen, Robbert J.
- Showing 1 - 7 results of 7
-
1
Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel od Belderbos, Bodine P.S., de Wit, Ronald, Hoop, Esther Oomen-de, Nieuweboer, Annemieke, Hamberg, Paul, van Alphen, Robbert J., Bergman, André, van der Meer, Nelly, Bins, Sander, Mathijssen, Ron H.J., van Soest, Robert J.
Izdano 2017Text -
2
The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors od Hussaarts, Koen G. A. M., Berger, Florine A., Binkhorst, Lisette, Oomen - de Hoop, Esther, van Leeuwen, Roelof W. F., van Alphen, Robbert J., Mathijssen - van Stein, Daniëlle, de Groot, Natasja M. S., Mathijssen, Ron H. J., van Gelder, Teun
Izdano 2019Text -
3
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study od Belderbos, Bodine P.S., Hussaarts, Koen G.A.M., van Harten, Leonie J., Oomen‐de Hoop, Esther, de Bruijn, Peter, Hamberg, Paul, van Alphen, Robbert J., Haberkorn, Brigitte C.M., Lolkema, Martijn P., de Wit, Ronald, van Soest, Robert J., Mathijssen, Ron H.J.
Izdano 2019Text -
4
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01) od van Rossum, Annelot G.J., Mandjes, Ingrid A.M., van Werkhoven, Erik, van Tinteren, Harm, van Leeuwen-Stok, A. Elise, Nederlof, Petra, Portielje, Johanna E.A., van Alphen, Robbert J., Platte, Els, van den Broek, Daan, Huitema, Alwin, Kok, Marleen, Linn, Sabine C., Oosterkamp, Hendrika M.
Izdano 2021Text -
5
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients od Binkhorst, Lisette, Kloth, Jacqueline S. L., de Wit, Annelieke S., de Bruijn, Peter, Lam, Mei H., Chaves, Ines, Burger, Herman, van Alphen, Robbert J., Hamberg, Paul, van Schaik, Ron H. N., Jager, Agnes, Koch, Birgit C. P., Wiemer, Erik A. C., van Gelder, Teun, van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Izdano 2015Text -
6
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer od Braal, C. Louwrens, Jager, Agnes, Hoop, Esther Oomen-de, Westenberg, Justin D., Lommen, Koen M. W. T., de Bruijn, Peter, Vastbinder, Mijntje B., van Rossum-Schornagel, Quirine C., Thijs-Visser, Martine F., van Alphen, Robbert J., Struik, Liesbeth E. M., Zuetenhorst, Hanneke J. M., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Izdano 2021Text -
7
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen od Hussaarts, Koen G.A.M., Hurkmans, Daan P., Oomen-de Hoop, Esther, van Harten, Leonie J., Berghuis, Stan, van Alphen, Robbert J., Spierings, Leontine E.A., van Rossum-Schornagel, Quirine C., Vastbinder, Mijntje B., van Schaik, Ron H.N., van Gelder, Teun, Jager, Agnes, van Leeuwen, Roelof W.F., Mathijssen, Ron H.J.
Izdano 2019Text